SARS-CoV-2 Spike antibody (C-Term)
Quick Overview for SARS-CoV-2 Spike antibody (C-Term) (ABIN7795562)
Target
See all SARS-CoV-2 Spike (SARS-CoV-2 S) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Purpose
- Rabbit anti-SARS-CoV-2 Spike RBD Antibody Affinity Purified
-
Purification
- Antigen Affinity Purified
-
Immunogen
- HEK293-derived SARS CoV-2 S-RBD protein Ala319-Phe541, with a C-terminal HIS6 tag
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB,110,000 - 125,000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- 2 - 8 °C
-
Expiry Date
- 12 months
-
-
- SARS-CoV-2 Spike (SARS-CoV-2 S)
-
Alternative Name
- SARS-CoV-2 Spike RBD
-
Target Type
- Viral Protein
-
Background
- The structural proteins of SARS-CoV-2 include the envelope protein (E), spike or surface glycoprotein (S), membrane protein (M) and the nucleocapsid protein (N). The spike glycoprotein is found on the outside of the virus particle and mediates attachment of the virus particle and entry into the host cell though an interaction with the virla receptor binding domain (RBD) and ACE2. The spike protein is an important target for vaccine development, antibody therapies and diagnostic antigen-based tests. (NCBI)
-
Gene ID
- 43740568
-
UniProt
- P0DTC2
Target
-